HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Membranous lipodystrophy presenting with palilalia: a PET study of cerebral glucose metabolism.

Abstract
A case of membranous lipodystrophy (Nasu-Hakola disease; NHD) associated with palilalia was reported. A 38-year-old Japanese woman developed walking difficulty in her twenties. At age 35 she manifested neuropsychiatric symptoms characterized by euphoria, palilalia and dementia. A bone marrow biopsy showed periodic acid Schiff-positive membranous cystic lesions in the adipose tissue. Positron emission tomography with (18F)-2-fluoro-2-deoxy-D-glucose disclosed that regional cerebral glucose metabolism was decreased in the bilateral frontal white matter with mild hypometabolism in the thalamus and basal ganglia; all predominantly on the right. Taken together with the previous postmortem findings, it is postulated that frontal lobe hypofunction, predominantly in the right hemisphere, produced the unique neuropsychiatric symptoms in this patient.
AuthorsY Ueki, N Kohara, T Oga, H Fukuyama, I Akiguchi, J Kimura, H Shibasaki
JournalActa neurologica Scandinavica (Acta Neurol Scand) Vol. 102 Issue 1 Pg. 60-4 (Jul 2000) ISSN: 0001-6314 [Print] Denmark
PMID10893065 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucose
Topics
  • Adult
  • Basal Ganglia (metabolism, physiopathology)
  • Brain (metabolism, physiopathology)
  • Dementia (diagnostic imaging, metabolism)
  • Diagnosis, Differential
  • Energy Metabolism
  • Female
  • Frontal Lobe (metabolism, physiopathology)
  • Glucose (metabolism)
  • Humans
  • Lipodystrophy (diagnostic imaging, metabolism)
  • Magnetic Resonance Imaging
  • Speech Disorders (diagnostic imaging, metabolism)
  • Thalamus (metabolism, physiopathology)
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: